http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018090054-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adff709a8d25eaa0d3871ff46ff250eb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
filingDate 2017-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13fa488b51e28f123203e8be8e687038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f9e4a238f3ebb6d0b34215e8ed364e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26870b0514d27339f24e9e7b19b6550f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2324b1b71d55bd49ff08b361c321d54f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c91a98d13f476dbf27f99df99e1549af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46d0c129c6da62c2ee35816671596993
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ecf5874b7b757deef6ee5b1e36af957
publicationDate 2019-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2018090054-A8
titleOfInvention Methods for treating parkinson's disease
abstract The present invention provides methods for treating Parkinson's Disease (PD), e.g., PD associated with a genetic mutation in a glucocerebrosidase (GBA) gene or a leucine rich repeat kinase 2 (LRRK2) gene. The methods comprise administering to the subject a modulator, e.g., an inhibitor, of p53-inducible gene 3 (PIG3).
priorityDate 2016-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID486608
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCH1AE13
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID535652
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID537087
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID42796
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID300160
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID449571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6106
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID318721
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID120892
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID745893
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID34835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID857
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID42447
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCI1BTD7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395985
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID427844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395986
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID559366
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID66725
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14466
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCH1AE12

Total number of triples: 49.